How the Eitan Group aims to disrupt the infusion pump industry

The Eitan Group’s Q Core Medical currently has over 100,000 Sapphire infusion pumps circulating in the world market.
[Image courtesy of Eitan Group]

Privately held Eitan Group wants to bring more infusion pumps into people’s homes. Can it compete against the established players?

Officials at the Eitan Group want to disrupt the infusion pump market by selling devices that are more connected and software-based — able to be used not only in hospitals but in the home.

Eitan is probably best known for its Q Core Medical company that makes Sapphire infusion pumps, which have been around for more than a decade. But Netanya, Israel-based Eitan also has its Avoset Medical business, marketing what it describes as simple, easy-to-use pumps for home healthcare settings. Sorrel Medical, Eitan’s third subsidiary, makes a wearable injector device that delivers biological drugs for chronic diseases.

Eitan in coming years is looking to grow the $50 million in annual sales it’s averaged over the past three years. The company in March hired Roger Massengale, previously VP & GM of Avanos Medical (formerly Halyard Health) as its North American CEO. Eitan opened its U.S. headquarters in Aliso Viejo, Calif., in June and is expanding its team there.

Get the full story on our sister site, Medical Design & Outsourcing.